Robert D. Goldin
Epidemiology · 2001–2019
A researcher in the Science corpus: 6 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 22 citations into it
- Hepatology — 16 citations into it
- Endocrinology, Diabetes and Metabolism — 7 citations into it
- Pathology and Forensic Medicine — 5 citations into it
Whom Robert D. Goldin trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Robert D. Goldin's perspective
Ordered by how strongly the researchers Robert D. Goldin trusts endorse each paper. Same corpus, a different order for every researcher.
- Molecular mediators of hepatic steatosis and liver injury. (Journal of Clinical Investigation)
- AGA technical review on nonalcoholic fatty liver disease. (Gastroenterology)
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome (Hepatology)
- Liver fibrosis in overweight patients. (Gastroenterology)
- Nonalcoholic steatohepatitis (Current treatment options in gastroenterology)
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease (Hepatology)
- Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ (Science)
- The epidemiology of cholangiocarcinoma. (Seminars in liver disease (Print))
- Defective Uptake and Utilization of Long Chain Fatty Acids in Muscle and Adipose Tissues of CD36 Knockout Mice* (Journal of Biological Chemistry)
- Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. (Gastroenterology)
Their papers
- Colonic epithelial cell diversity in health and inflammatory bowel disease (2019) — 722 citations
- Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update (2012) — 767 citations
- Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research (2006) — 750 citations
- Histological outcome during long-term lamivudine therapy. (2003) — 762 citations
- Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document (2002) — 668 citations
- Dysfunction of endothelial protein C activation in severe meningococcal sepsis. (2001) — 691 citations